# K042309: Biosomnia-V3

- Pathway: 510(k) (Traditional)
- Applicant: Oxford Biosignals Limited
- Decided: Sep 8, 2004 after 14 days
- Product code: OMC (Reduced- Montage Standard Electroencephalograph)
- Device class: 2
- Regulation: 21 CFR 882.1400
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
No later device cites it as a predicate yet.
0 of 1 device in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. FDA’s file for it is a 510(k) statement, which names no predicate.

## Indications for use
Oxford Biosignals BioSomaia V3 is a three channel ambulatory device providing signal amplification of two channels of EEG and one of EMG and connections to external devices for subsequent EEG / EMG signal display, storage and analysis. The device is designed to be used overnight in the patient’s home environment to assist the physician in diagnosing sleep disorders.

Source page: https://510kreport.com/device/K042309
Methodology: https://510kreport.com/methodology